PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Clinical trials for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug switch study aims to guide treatment for serious lung disease
Disease control Recruiting nowThis study is observing what happens when adults with pulmonary arterial hypertension (PAH) switch from one standard medication (ambrisentan) to another (bosentan). Researchers will track 121 patients for 3-6 months to see if this change affects their overall risk score, which pr…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Patients wait years for Life-Threatening disease diagnosis
Knowledge-focused Recruiting nowThis study aims to understand why it takes so long for patients in Brazil to get diagnosed with pulmonary arterial hypertension (PAH) and other rare diseases. Researchers will review medical records of 139 adults diagnosed within the last five years to track their journey from fi…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: University of Sao Paulo General Hospital • Aim: Knowledge-focused
Last updated Apr 02, 2026 02:26 UTC
-
Scientists seek 10,000 volunteers to unlock genetic secrets of lung pressure disease
Knowledge-focused Recruiting nowThis online research study aims to understand how genetics influence a person's risk of developing pulmonary hypertension, a condition affecting blood pressure in the lungs. The study is recruiting 10,000 adults living in the United States, and participants do not need to have a …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
New survey aims to unlock better care for lung disease patients
Knowledge-focused Recruiting nowThis study is creating and testing a questionnaire to find out what patients with pulmonary arterial hypertension (PAH) know about their condition. Researchers will work with about 200 patients to make sure the questions are clear and measure knowledge accurately. The goal is to …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: NA • Sponsor: University of Sao Paulo General Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC